Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Letrozole reduces seizures but not brain damage in mice.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Activating PKM2 and Wnt/β-catenin signaling together can potentially enhance hair growth and could be a treatment for hair loss.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Potassium channel openers like minoxidil boost hair growth.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Blocking DKK1 with siRNA can improve hair growth.